News
The addition of a candidate targeting glucagon, as well as GLP-1 and GIP ... A total of 36 patients were enrolled in three different dose groups (1mg, 1mg/3mg, 1mg/3mg/6mg).
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback